{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:59:06Z","timestamp":1790107146328,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.lpm.2017.09.019","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T14:03:46Z","timestamp":1513692226000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Art\u00e9riopathie des membres inf\u00e9rieurs\u00a0: le traitement"],"prefix":"10.1016","volume":"47","author":[{"given":"Il\u00e9ana","family":"Desormais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Pesteil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipe","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2017.09.019_bib0185","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery. Practice guidelines for atherosclerotic occlusive disease of the lower extremities\u00a0: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"issue":"12","key":"10.1016\/j.lpm.2017.09.019_bib0190","doi-asserted-by":"crossref","first-page":"e726","DOI":"10.1161\/CIR.0000000000000471","article-title":"2016 AHA\/ACC Guideline on the management of patients with lower extremity peripheral artery disease\u00a0: executive summary. a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lpm.2017.09.019_bib0195","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.111.075770","article-title":"Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease. Six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study","volume":"125","author":"Murphy","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2017.09.019_bib0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/bjs.7710","article-title":"Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease","volume":"99","author":"Mazari","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.lpm.2017.09.019_bib0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2008.962","article-title":"Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial","volume":"301","author":"McDermott","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2017.09.019_bib0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jvs.2006.03.037","article-title":"Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease","volume":"44","author":"Sanderson","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.lpm.2017.09.019_bib0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1358863X08101858","article-title":"Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication","volume":"14","author":"Treat-Jacobson","year":"2009","journal-title":"Vasc Med"},{"key":"10.1016\/j.lpm.2017.09.019_bib0220","article-title":"Exercise for intermittent claudication","volume":"7","author":"Lane","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2017.09.019_bib0225","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/bjs.10247","article-title":"Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication","volume":"103","author":"van den Houten","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.lpm.2017.09.019_bib0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5694\/j.1326-5377.1983.tb99395.x","article-title":"The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease","volume":"1","author":"Faulkner","year":"1983","journal-title":"Med J Aust"},{"key":"10.1016\/j.lpm.2017.09.019_bib0235","first-page":"635","article-title":"Cigarette smoking and the outcome after lower limb arterial surgery","volume":"154","author":"Lassila","year":"1988","journal-title":"Acta Chir Scand"},{"key":"10.1016\/j.lpm.2017.09.019_bib0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jvs.2005.03.024","article-title":"Smoking and the patency of lower extremity bypass grafts: a meta-analysis","volume":"42","author":"Willigendael","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.lpm.2017.09.019_bib0245","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2017.09.019_bib0250","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2017.09.019_bib0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9149(97)00904-1","article-title":"Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)","volume":"81","author":"Pedersen","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lpm.2017.09.019_bib0260","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2017.09.019_bib0265","first-page":"CD000123","article-title":"Lipid-lowering for peripheral arterial disease of the lower limb","volume":"4","author":"Aung","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2017.09.019_bib0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.2012.216237","article-title":"Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial","volume":"309","author":"Ahimastos","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2017.09.019_bib0275","first-page":"CD005508","article-title":"Beta blockers for peripheral arterial disease","volume":"9","author":"Paravastu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2017.09.019_bib0280","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2017.09.019_bib0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2017.09.019_bib0290","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.112.000679","article-title":"Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50","volume":"127","author":"Bonaca","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2017.09.019_bib0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N Engl J Med"},{"issue":"Suppl A","key":"10.1016\/j.lpm.2017.09.019_bib0300","first-page":"1","article-title":"Second European consensus document on chronic critical leg ischemia","year":"1992","journal-title":"Eur J Vasc"},{"key":"10.1016\/j.lpm.2017.09.019_bib0305","doi-asserted-by":"crossref","first-page":"e0135692","DOI":"10.1371\/journal.pone.0135692","article-title":"Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis","volume":"10","author":"Katsanos","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.lpm.2017.09.019_bib0310","first-page":"CD002071","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","volume":"8","author":"Robertson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2017.09.019_bib0315","first-page":"CD000535","article-title":"Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery","volume":"2","author":"Bedenis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2017.09.019_bib0320","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.0954-6820.1987.tb00891.x","article-title":"Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality","volume":"221","author":"Jonason","year":"1987","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.lpm.2017.09.019_bib0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"issue":"9038","key":"10.1016\/j.lpm.2017.09.019_bib0330","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2017.09.019_bib0335","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin dose for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2017.09.019_bib0340","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"a","key":"10.1016\/j.lpm.2017.09.019_bib0345","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2017.09.019_bib0350","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for Asymptomatic Atherosclerosis Trialists. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"Fowkes","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2017.09.019_bib0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2017.09.019_bib0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498217304414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498217304414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T07:32:18Z","timestamp":1570519938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498217304414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0755498217304414"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2017.09.019","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Art\u00e9riopathie des membres inf\u00e9rieurs\u00a0: le traitement","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2017.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}